Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab
Clinical trial NCT06710223 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06710223
- Sponsor
- University of California, San Diego
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-03
- Primary completion
- 2027-12-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.